Measurement of rivaroxaban and apixaban in serum samples of patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Measurement of rivaroxaban and apixaban in serum samples of patients
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume 44, Issue 8, Pages 743-752
Publisher
Wiley
Online
2014-06-17
DOI
10.1111/eci.12291
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH
- (2014) J. Harenberg et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparative Effectiveness of New Oral Anticoagulants and Standard Thromboprophylaxis in Patients Having Total Hip or Knee Replacement
- (2013) Soheir S. Adam et al. ANNALS OF INTERNAL MEDICINE
- The laboratory and the direct oral anticoagulants
- (2013) A. Tripodi BLOOD
- Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects
- (2013) Vijay V. Upreti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects
- (2013) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Simultaneous UPLC–MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma
- (2013) JoEtta M. Juenke et al. CLINICA CHIMICA ACTA
- The role of the laboratory in treatment with new oral anticoagulants
- (2013) T. Baglin JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study
- (2013) Meyer Michel Samama et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate
- (2013) Jean-Michel Dogné et al. THROMBOSIS AND HAEMOSTASIS
- Monitoring plasma levels of factor Xa inhibitors: how, why and when?
- (2013) Meyer-Michel Samama et al. Expert Review of Hematology
- Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
- (2013) L. A. Castellucci et al. BMJ-British Medical Journal
- Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism
- (2012) Zhe-Yi Hu et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects
- (2012) Sebastian Härtter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: Improved applicability to pharmacokinetic study
- (2012) Zhe-Yi Hu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban
- (2012) J. HARENBERG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Quality Standards for Sample Collection in Coagulation Testing
- (2012) Giuseppe Lippi et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada
- (2012) Michael Sharma et al. THROMBOSIS AND HAEMOSTASIS
- Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: What’s next?
- (2012) Svetlana Marx et al. THROMBOSIS AND HAEMOSTASIS
- Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery
- (2012) J. Harenberg et al. THROMBOSIS AND HAEMOSTASIS
- Determination of the anticoagulant effects of new oral anticoagulants: an unmet need
- (2012) Job Harenberg et al. Expert Review of Hematology
- Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
- (2012) B. D. Fox et al. BMJ-British Medical Journal
- Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
- (2011) Kan He et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability
- (2011) Job Harenberg et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
- (2011) Richard C. Becker et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time
- (2011) Christian Hesse et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls
- (2011) Genevieve Contant et al. THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests
- (2011) L.M. Asmis et al. THROMBOSIS RESEARCH
- An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma
- (2010) Jean Amiral et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor
- (2010) Jean-Luc Martinoli et al. THROMBOSIS AND HAEMOSTASIS
- Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery
- (2009) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Determination of rivaroxaban – a novel, oral, direct Factor Xa inhibitor – in human plasma by high-performance liquid chromatography–tandem mass spectrometry
- (2008) G. Rohde JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: Current status and future considerations
- (2007) Donna M. Bush FORENSIC SCIENCE INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More